These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50 related articles for article (PubMed ID: 21365766)
1. Biological effects of MC2050, a quinazoline-based PARP-1 inhibitor, in human neuroblastoma and EBV-positive Burkitt's lymphoma cells. Mosca L; Rotili D; Tempera I; Masci A; Fontana M; Chiaraluce R; Mastromarino P; d'Erme M; Mai A ChemMedChem; 2011 Apr; 6(4):606-11. PubMed ID: 21365766 [No Abstract] [Full Text] [Related]
2. Resistance-modifying agents. 5. Synthesis and biological properties of quinazolinone inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase (PARP). Griffin RJ; Srinivasan S; Bowman K; Calvert AH; Curtin NJ; Newell DR; Pemberton LC; Golding BT J Med Chem; 1998 Dec; 41(26):5247-56. PubMed ID: 9857092 [TBL] [Abstract][Full Text] [Related]
3. Discovery of quinazolinone and quinoxaline derivatives as potent and selective poly(ADP-ribose) polymerase-1/2 inhibitors. Iwashita A; Hattori K; Yamamoto H; Ishida J; Kido Y; Kamijo K; Murano K; Miyake H; Kinoshita T; Warizaya M; Ohkubo M; Matsuoka N; Mutoh S FEBS Lett; 2005 Feb; 579(6):1389-93. PubMed ID: 15733846 [TBL] [Abstract][Full Text] [Related]
4. Involvement of caspase activation and mitochondrial stress in trichostatin A-induced apoptosis of Burkitt's lymphoma cell line, Akata. Son YO; Choi KC; Lee JC; Kook SH; Lee HJ; Jeon YM; Kim JG; Kim J; Lee WK; Jang YS J Cell Biochem; 2006 Dec; 99(5):1420-30. PubMed ID: 16817225 [TBL] [Abstract][Full Text] [Related]
5. Novel potent inhibitors of the DNA repair enzyme poly(ADP-ribose)polymerase (PARP). Griffin RJ; Pemberton LC; Rhodes D; Bleasdale C; Bowman K; Calvert AH; Curtin NJ; Durkacz BW; Newell DR; Porteous JK Anticancer Drug Des; 1995 Sep; 10(6):507-14. PubMed ID: 7575991 [No Abstract] [Full Text] [Related]
6. Discovery of novel quinazoline-2,4(1H,3H)-dione derivatives as potent PARP-2 selective inhibitors. Zhao H; Ji M; Cui G; Zhou J; Lai F; Chen X; Xu B Bioorg Med Chem; 2017 Aug; 25(15):4045-4054. PubMed ID: 28622906 [TBL] [Abstract][Full Text] [Related]
7. Phenylbutyrate induces cell differentiation and modulates Epstein-Barr virus gene expression in Burkitt's lymphoma cells. Bar-Ner M; Thibault A; Tsokos M; Magrath IT; Samid D Clin Cancer Res; 1999 Jun; 5(6):1509-16. PubMed ID: 10389940 [TBL] [Abstract][Full Text] [Related]
8. Azidothymidine and interferon-alpha induce apoptosis in herpesvirus-associated lymphomas. Lee RK; Cai JP; Deyev V; Gill PS; Cabral L; Wood C; Agarwal RP; Xia W; Boise LH; Podack E; Harrington WJ Cancer Res; 1999 Nov; 59(21):5514-20. PubMed ID: 10554028 [TBL] [Abstract][Full Text] [Related]
9. Contrasting effects of hydroxyurea on cell growth and reduction in Epstein-Barr virus genomes in EBV-infected epithelioid cell lines vs Burkitt's lymphoma cell lines. Jiang R; Kanamori M; Satoh Y; Fukuda M; Ikuta K; Murakami M; Sairenji T J Med Virol; 2003 Jun; 70(2):244-52. PubMed ID: 12696111 [TBL] [Abstract][Full Text] [Related]
10. Flavopiridol induces apoptosis and caspase-3 activation of a newly characterized Burkitt's lymphoma cell line containing mutant p53 genes. Rapoport AP; Simons-Evelyn M; Chen T; Sidell R; Luhowskyj S; Rosell K; Obrig T; Hicks D; Hinkle PM; Nahm M; Insel RA; Abboud CN Blood Cells Mol Dis; 2001; 27(3):610-24. PubMed ID: 11482875 [TBL] [Abstract][Full Text] [Related]
11. Modulation of the antiproliferative activity of anticancer drugs in hematopoietic tumor cell lines by the poly(ADP-ribose) polymerase inhibitor 6(5H)-phenanthridinone. Holl V; Coelho D; Weltin D; Hyun JW; Dufour P; Bischoff P Anticancer Res; 2000; 20(5A):3233-41. PubMed ID: 11062748 [TBL] [Abstract][Full Text] [Related]
12. Replacement of the Epstein-Barr virus plasmid with the EBER plasmid in Burkitt's lymphoma cells. Maruo S; Nanbo A; Takada K J Virol; 2001 Oct; 75(20):9977-82. PubMed ID: 11559830 [TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus and Burkitt's lymphoma. Magrath I; Jain V; Bhatia K Semin Cancer Biol; 1992 Oct; 3(5):285-95. PubMed ID: 1335792 [TBL] [Abstract][Full Text] [Related]
14. Discovery and SAR of novel, potent and selective hexahydrobenzonaphthyridinone inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1). Torrisi C; Bisbocci M; Ingenito R; Ontoria JM; Rowley M; Schultz-Fademrecht C; Toniatti C; Jones P Bioorg Med Chem Lett; 2010 Jan; 20(2):448-52. PubMed ID: 20015648 [TBL] [Abstract][Full Text] [Related]
15. Rational approaches to discovery of orally active and brain-penetrable quinazolinone inhibitors of poly(ADP-ribose)polymerase. Hattori K; Kido Y; Yamamoto H; Ishida J; Kamijo K; Murano K; Ohkubo M; Kinoshita T; Iwashita A; Mihara K; Yamazaki S; Matsuoka N; Teramura Y; Miyake H J Med Chem; 2004 Aug; 47(17):4151-4. PubMed ID: 15293985 [TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effects of NU1025, a PARP inhibitor in cerebral ischemia are mediated through reduction in NAD depletion and DNA fragmentation. Kaundal RK; Shah KK; Sharma SS Life Sci; 2006 Nov; 79(24):2293-302. PubMed ID: 16935310 [TBL] [Abstract][Full Text] [Related]